Bio Rad Laboratories Inc
NYSE:BIO
Bio Rad Laboratories Inc
NYSE:BIO
Price:
300.63 USD
2.25%
Updated:
May 15, 2024
Bio Rad Laboratories Inc
Income from Continuing Operations
|
Bio Rad Laboratories Inc
Income from Continuing Operations Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bio Rad Laboratories Inc
NYSE:BIO
|
Income from Continuing Operations
-$322.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Income from Continuing Operations
$6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
|
Danaher Corp
NYSE:DHR
|
Income from Continuing Operations
$7.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
28%
|
CAGR 10-Years
12%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Income from Continuing Operations
$777.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Income from Continuing Operations
$1.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
1%
|
CAGR 10-Years
22%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Income from Continuing Operations
$1.4B
|
CAGR 3-Years
65%
|
CAGR 5-Years
42%
|
CAGR 10-Years
20%
|
See Also
What is Bio Rad Laboratories Inc's Income from Continuing Operations?
Income from Continuing Operations
-322.4m
USD
-322.4m
USD
Based on the financial report for Mar 31, 2024, Bio Rad Laboratories Inc's Income from Continuing Operations amounts to -322.4m USD.
What is Bio Rad Laboratories Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
-74%
-74%
Over the last year, the Income from Continuing Operations growth was -74%.
You don't have any saved screeners yet
